# Dexmedetomidine in Children for Magnetic Resonance Imaging (MRI) Sedation

> **NCT02299232** · PHASE4 · COMPLETED · sponsor: **Sisli Hamidiye Etfal Training and Research Hospital** · enrollment: 60 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT02299232
- **Lead sponsor:** Sisli Hamidiye Etfal Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02299232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02299232, "Dexmedetomidine in Children for Magnetic Resonance Imaging (MRI) Sedation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02299232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*